ResApp Health (acquired by Pfizer)

medical devices

About

ResApp Health is a digital health company based in Brisbane, Australia, specializing in smartphone-based diagnostic and management solutions for respiratory diseases. Founded in 2014, the company utilizes sound analysis technology to diagnose conditions such as asthma, pneumonia, and chronic obstructive pulmonary disease (COPD). ResApp Health is now a subsidiary of Pfizer Australia Holdings Pty Ltd, following its acquisition in 2021. The company's core products include ResAppDx-EU, a diagnostic test for acute respiratory diseases suitable for various healthcare settings, and SleepCheck, an app for at-home screening of sleep apnea. ResApp's technology is clinically validated and regulatory cleared, designed to integrate with telehealth platforms, making it accessible for healthcare providers and consumers alike. The company aims to enhance the diagnosis and management of respiratory conditions, empowering patients to take control of their health remotely.

Technologies

Microsoft Office 365 DynECT Gmail Google Apps Zendesk React Native Android Remote Viewpoint

Keywords

digital health disease diagnosis disease management respiratory disease medical equipment manufacturing health wellness & fitness information technology & services medical devices hospital & health care

Location

127 Creek Street, Brisbane City, Queensland, Australia, 4000

Related Companies

Companies in the same industry